Jarrod Longcor
CIK 1545565 · Chief Operating Officer · last filed 2026-07-08
Jarrod Longcor is a Chief Operating Officer who has filed 22 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for CLRB, was dated Jul 8, 2026. Across all open-market trades the lifetime net is +$184.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $51.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$51.1K
3
22
$184.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CLRB | Chief Operating Officer | 20,451 | $2.50 | $51.1K | $83.3K | 9 | 2026-07-08 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Chief Business Officer | 102,148 | $0.12 | $12.2K | $100.8K | 12 | 2021-03-05 |
| Cellectar Biosciences, Inc. (CLRB.W) Delisted | Sr. VP of Corp Dev & Ops | — | — | — | $0 | 1 | 2016-08-12 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-08 | CLRB | Grant (A) | — | $0 | EDGAR |
| 2026-05-11 | CLRB | Buy (P) | +8,680 | $25.0K | EDGAR |
| 2025-07-03 | CLRB | Buy (P) | +10,000 | $49.9K | EDGAR |
| 2025-03-12 | CLRB | Buy (P) | +30,000 | $8.4K | EDGAR |
| 2025-02-18 | CLRB | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | CLRB | Grant (A) | — | $0 | EDGAR |
| 2023-12-12 | CLRB | Grant (A) | +42,927 | $0 | EDGAR |
| 2023-01-18 | CLRB | Grant (A) | — | $0 | EDGAR |
| 2022-01-27 | CLRB | Grant (A) | — | $0 | EDGAR |
| 2021-03-05 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.